Multicenter, open-label, non-interventional study to evaluate the impact on clinical effects, user-friendliness and patient's acceptance of Airflusal® Forspiro® in the treatment of asthma under real life conditions (ASSURE) First published 03/02/2016 Last updated 01/04/2024 EU PAS number:EUPAS12236 Study Finalised